Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1991 Jun;84(3):493-500.

Analysis of viral proteins in circulating immune complexes from chronic carriers of hepatitis B virus

Affiliations

Analysis of viral proteins in circulating immune complexes from chronic carriers of hepatitis B virus

K Madalinski et al. Clin Exp Immunol. 1991 Jun.

Abstract

Sera from 54 children (mean age 5.8 years) with chronic hepatitis B virus (HBV) infection were investigated for the presence of immune complexes containing HBV proteins. Clinical diagnosis was established by histology and biochemical markers and included chronic persistent (36 cases) or chronic aggressive (seven) hepatitis, liver cirrhosis (six) and HBV-mediated membranous glomerulonephritis (five). Circulating immune complexes were precipitated with 2.5% polyethylene glycol and analysed by immune blot using monoclonal antibodies against S, pre-S2 glycopeptide, pre-S1 and HBe/c epitopes. All sera, including those from 11 healthy HBV-negative blood donors contained PEG-precipitable substances, but the amount of precipitate did not correlate with the presence or amount of HBV proteins. The great majority (36 out of 40) of HBeAg-positive patients contained HBs proteins in immune complexes, but no detectable HBe protein. The immune complexes usually contained more pre-S1 than the free HBsAg particles from the same patient. The precipitates of anti-HBe-positive patients rarely contained HBV proteins (two out of 14) and, if so, in low amounts. During follow up of six patients we found that high levels of HBs-containing immune complexes may be correlated with subsequent elimination of HBV. This elimination is possibly initiated by binding of anti-pre-S1 antibodies to HBV and HBs particles.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Wien Klin Wochenschr. 1984 Sep 28;96(18):669-73 - PubMed
    1. J Immunol. 1982 Dec;129(6):2773-8 - PubMed
    1. Eur J Clin Microbiol. 1986 Jun;5(3):330-5 - PubMed
    1. J Clin Microbiol. 1986 Aug;24(2):288-93 - PubMed
    1. J Virol Methods. 1986 Sep;14(2):141-51 - PubMed

Publication types

Substances

LinkOut - more resources